Article ; Online: Systemic Therapy in Metastatic Hepatocellular Carcinoma.
Current gastroenterology reports
2022 Volume 24, Issue 5, Page(s) 65–71
Abstract: Purpose of review: Multiple new tyrosine kinase inhibitors, immunotherapies and anti-angiogenic therapies are now available for the treatment of advanced hepatocellular carcinoma (HCC). In this article, we reviewed the evidence supporting these new ... ...
Abstract | Purpose of review: Multiple new tyrosine kinase inhibitors, immunotherapies and anti-angiogenic therapies are now available for the treatment of advanced hepatocellular carcinoma (HCC). In this article, we reviewed the evidence supporting these new therapies. Recent findings: The combination of atezolizumab and bevacizumab has become a new standard of care for initial systemic therapy in eligible patients, replacing sorafenib in the first line for many patients. Lenvatinib, a multikinase inhibitor, is also a new first line treatment option for patients who are not eligible for immunotherapy. Several additional options for second line treatment were also reviewed in detail in this paper. New systemic therapies for advanced HCC have prolonged overall survival. However, these new therapies are primarily approved for patients with Child-Pugh A classification with few options for patients with Child-Pugh B disease. Further work is needed to expand options for patients with more advanced liver disease and to optimize the sequencing of these new therapies. |
---|---|
MeSH term(s) | Carcinoma, Hepatocellular/drug therapy ; Humans ; Immunotherapy ; Liver Neoplasms/drug therapy ; Sorafenib/therapeutic use |
Chemical Substances | Sorafenib (9ZOQ3TZI87) |
Language | English |
Publishing date | 2022-04-13 |
Publishing country | United States |
Document type | Journal Article ; Review |
ZDB-ID | 2041376-2 |
ISSN | 1534-312X ; 1522-8037 |
ISSN (online) | 1534-312X |
ISSN | 1522-8037 |
DOI | 10.1007/s11894-022-00842-9 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5751: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.